Episode 203: PREMIUM – Vitamin D, chelation therapy, and obesity studies you need to know about

In episode 203, James and Mike go all PREMIUM and discuss three new studies. Vitamin D for the common cold, chelation therapy post-MI and the link between obesity and mortality. If you are reading this and you are a non-PREMIUM member, boy are you missing something.

 Show notes

1) Vitamin D for the cold Read more »

Episode 63: More listener questions with answers leaving more questions

In episode 63, we again let the listeners take control as we try to deal with the excellent questions and comments that come our way. We get into a heavy discussion around issues of weight and weight loss. Mike asks James a number of questions that make him squirm and James thanks him because fidgeting is a great way to burn calories.

Show Notes Read more »

Episode 53: CRP - An important part of a Comprehensive Risk Profile or a Completely Ridiculous Practice- Part II

Episode 53 continues where we left with the whole CRP measurement or no measurement discussion. James and Mike start with the Reynolds Risk Score and show how even at the extremes of CRP, absolute risks only change by around +/- 2% or so. Read more »

Episode 43: Obesity – what’s the big deal? - Part III

In episode 43, we take our last run/jog at the problem of obesity by exercising our right to talk about the benefits of increasing activity. Read more »

Episode 42: Obesity – what’s the big deal? - Part II

In episode 42, we continue to take a bite out of the big problem of obesity by getting down and dirty with “diets” and drugs. As usual, lifestyle issues win out and James and Mike celebrate this news by pigging out - but it’s OK because we used small plates.

Show Notes

1) Lifestyle beats out drugs

Stopping patients with IGT going to DM Read more »

Episode 41: Obesity – what’s the big deal?

In episode 41, we start to tackle the big problem of obesity by getting the advice of 2 Mikes for the price of one. We discuss how classification is more useful from an epidemiologic perspective than it is from an individual patient perspective – which is often the case in medicine. In the end, the team heads to a local fast food restaurant to verify the evidence for caloric binging. Read more »

Syndicate content